Vascularization of testicular germ cell tumours: Evidence from experimental teratocarcinomas

International Journal of Andrology

Volumn 33, Issue 6, 2010, Pages 765-774

  Silvan U ^a   Diez Torre A ^a   Jimenez Rojo L ^a   Arechaga J ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Angiogenesis; Cancer microenvironment; Cancer stem cell; Hypoxia; Teratocarcinoma; Tumour vascularization

Indexed keywords

BEVACIZUMAB; CELL ADHESION MOLECULE; CILENGITIDE; ETARACIZUMAB; MATRIX METALLOPROTEINASE; SUNITINIB; THALIDOMIDE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VINBLASTINE;

CANCER STEM CELL; CELL HYPOXIA; DRUG ACTIVITY; GERM CELL TUMOR; HUMAN; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TERATOCARCINOMA; TESTIS TUMOR; TUMOR MICROENVIRONMENT;

ADOLESCENT; ADULT; ANGIOGENESIS INHIBITORS; ANIMALS; CADHERINS; CELL ADHESION MOLECULES; EMBRYONIC STEM CELLS; HUMANS; INTEGRINS; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASES; NEOPLASM METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOVASCULARIZATION, PATHOLOGIC; TERATOCARCINOMA; TESTICULAR NEOPLASMS; TESTIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957139858     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2010.01068.x     Document Type: Review

References (75)

1. Aigner A, Brachmann P, Beyer J, Jäger R, Raulais D, Vigny M et al. (2003) Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients. Ann Oncol 14, 1525-1529.
2. Alfranca A, López-Oliva JM, Genís L, López-Maderuelo D, Mirones I, Salvado D, Quesada AJ, Arroyo AG & Redondo JM. (2009) PGE2 induces angiogenesis via MT1-MMP-mediated activation of the TGFbeta/Alk5 signaling pathway. Blood 112, 1120-1128.
3. Almstrup K, Sonne SB, Hoei-Hansen CE, Ottesen AM, Nielsen JE, Skakkebaek NE, Leffers H & Rajpert-De Meyts E. (2006) From embryonic stem cells to testicular germ cell cancer - should we be concerned? Int J Androl 29, 211-218.
4. Ardi VC, Kupriyanova TA, Deryugina EI & Quigley JP. (2007) Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci USA 104, 20262-20267.
5. Arrieta O, Michel Ortega RM, Angeles-Sánchez J, Villarreal-Garza C, Avilés-Salas A, Chanona-Vilchis JG, Aréchaga-Ocampo E, Luévano-González A, Jiménez MA & Aguilar JL. (2009) Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors. J Exp Clin Cancer Res 28, 120-126.
6. Arroyo AG, Genís L, Gonzalo P, Matías-Román S, Pollán A & Gálvez BG. (2007) Matrix metalloproteinases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease. Curr Pharm Des 13, 1787-1802.
7. Basile JR, Holmbeck K, Bugge TH & Gutkind JS. (2007) MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem 282, 6899-6905.
8. Bentas W, Beecken WD, Glienke W, Binder J & Schuldes H. (2003) Serum levels of basic fibroblast factor reflects disseminated disease in patients with testicular germ cell tumors. Urol Res 30, 390-393.
9. Bloch W, Forsberg E, Lentini S, Brakebusch C, Martin K, Krell HW, Weidle UH, Addicks K & Fässler R. (1997) β1 integrin is essential for teratoma growth and angiogenesis. J Cell Biol 139, 265-278.
10. Buerkle MA, Pahernik SA, Sutter A, Jonczyk A, Messmer K & Dellian M. (2002) Inhibition of the alpha-V integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo. Br J Cancer 86, 788-795.
11. Caires KC, De Avila J & McLean DJ. (2009) Vascular endothelial growth factor regulates germ cell survival during establishment of spermatogenesis in the bovine testis. Reproduction 138, 667-677.
12. Calaminus G, Schneider DT, Weissbach L, Schönberger S, Okpanyi V, Leuschner I, Poremba C & Göbel U. (2009) Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor. Klin Padiatr 221, 136-140.
13. Carmeliet P. (2003) Angiogenesis in health and disease. Nat Med 9, 653-660.
14. Castillo-Avila W, Piulats JM, Garcia Del Muro X, Vidal A, Condom E, Casanovas O et al. (2009) Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors. Clin Cancer Res 15, 3384-3395.
15. Catizone A, Ricci G, Arista V, Innocenzi A & Galdieri M. (1999) Hepatocyte growth factor and c-MET are expressed in rat prepuberal testis. Endocrinology 140, 3106-3212.
16. De Wever O & Mareel M. (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200, 429-447.
17. Demir R, Dimmler A, Naschberger E, Demir I, Papadopoulos T, Melling N, Sturzl M & Hohenberger W. (2009) Malignant progression of invasive tumor cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumor front. Exp Mol Pathol 87, 109-116.
18. Derycke L, Morbidelli L, Ziche M, De Wever O, Bracke M & Van Aken E. (2006) Soluble N-cadherin fragment promotes angiogenesis. Clin Exp Metastasis 23, 187-201.
19. Di Tomaso E, Capen D, Haskell A, Hart J, Logie JJ, Jain RK, McDonald DM, Jones R & Munn LL. (2005) Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial cell markers. Cancer Res 65, 5740-5749.
20. Díez-Torre A, Silván U, De Wever O, Bruyneel E, Mareel M & Aréchaga J. (2004) Germinal tumor invasion and the role of the testicular stroma. Int J Dev Biol 48, 545-557.
21. Ergün S, Kiliç N, Fiedler W & Mukhopadhyay AK. (1997) Vascular endothelial growth factor and its receptors in normal human testicular tissue. Mol Cell Endocrinol 131, 9-20.
22. Ezhilarasan R, Jadhav U, Mohanam I, Rao JS, Gujrati M & Mohanam S. (2009) The hemopexin domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice. Int J Cancer 124, 306-315.
23. Favilla V, Cimino S, Madonia M & Morgia G. (2010) New advances in clinical biomarkers in testis cancer. Front Biosci 2, 456-477.
24. Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R & Mitchell MA. (1994) Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 162, 499-510.
25. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D & Birchmeier W. (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113, 173-185.
26. Greco O & Scott S. (2007) Tumor hypoxia and targeted gene therapy. Int Rev Cytol 257, 181-212.
27. Gutheil JC, Campbell TN, Pierce PR, Watkins JD, Huse WD, Bodkin DJ & Cheresh DA. (2000) Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3. Clin Cancer Res 6, 3056-3061.
28. Hawinkels LJ, Zuidwijk K, Verspaget HW, De Jonge-Muller ES, Van Duijn W, Ferreira V et al. (2008) VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. Eur J Cancer 44, 1904-1913.
29. Hoeben E, Van Aelst I, Swinnen JV, Opdenakker G & Verhoeven G. (1996) Gelatinase A secretion and its control in peritubular and Sertoli cell cultures: effects of hormones, second messengers and inducers of cytokine production. Mol Cell Endocrinol 118, 37-46.
30. Hu GF, Strydom DG, Fett JW, Riordan JF & Vallee BL. (1993) Actin is a binding protein for angiogenin. Proc Natl Acad Sci USA 90, 1217-1221.
31. Jones A, Fujiyama C, Turner K, Fuggle S, Cranston D, Turley H, Valtola R, Bicknell R & Harris AL. (2000) Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis. Br J Urol Int 86, 80-86.
32. Josefsen D, Ous S, Hoie J, Stenwig AE & Fosså SD. (1993) Salvage treatment in male patients with germ cell tumours. Br J Cancer 67, 568-572.
33. Kim KI, Cho HJ, Hahn JY, Kim TY, Park KW, Koo BK et al. (2006) Beta-catenin over-expression augments angiogenesis and skeletal muscle regeneration through dual mechanism of vascular endothelial growth factor-mediated endothelial cell proliferation and progenitor cell mobilization. Arterioscler Thromb Vasc Biol 26, 91-98.
34. Kita D, Takino T, Nakada M, Takahashi T, Yamashita J & Sato H. (2001) Expression of dominant-negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin alpha5 expression in U251 glioma cell line. Cancer Res 61, 7985-7991.
35. Koga K, Osuga Y, Yano T, Ikezuki Y, Yoshino O, Hirota Y et al. (2004) Evidence for the presence of angiogenin in human testis. J Androl 25, 369-374.
36. Kruszewski WJ, Rzepko R, Wojtacki J, Skokowski J, Kopacz A, Jaskiewicz K & Drucis K. (2004) Over-expression of cathepsin B correlates with angiogenesis in colon adenocarcinoma. Neoplasma 51, 38-43.
37. Kumar S, Guleria R, Singh V, Bharti AC, Mohan A & Das BC. (2009) Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer. BMC Cancer 9, 421.
38. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L et al. (2001) Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412, 877-874.
39. LeCouter J, Lin R, Tejada M, Frantz G, Peale F, Hillan KJ & Ferrara N. (2003) The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci USA 100, 2685-2690.
40. Lee SJ, Kim JG, Sohn SK, Chae YS, Moon JH, Kim SN, Bae HI, Chung HY & Yu W. (2009) No association of vascular endothelial growth factor-A (VEGF-A) and VEGF-C expression with survival in patients with gastric cancer. Cancer Res Treat 41, 218-223.
41. Li Y, Kido T, Luo J, Fukuda M, Dobrinski I & Lau YF. (2008) Intratubular transplantation as a strategy for establishing animal models of testicular germ cell tumours. Int J Exp Pathol 89, 342-349.
42. Lissbrant IF, Lissbrant E, Persson A, Damber JE & Bergh A. (2003) Endothelial cell proliferation in male reproductive organs of adult rat is high and regulated by testicular factors. Biol Reprod 68, 1107-1111.
43. Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C et al. (2006) Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 116, 2132-2141.
44. Mimura T, Han KY, Onguchi T, Chang JH, Kim TI, Kojima T, Zhou Z & Azar DT. (2009) MT1-MMP-mediated cleavage of decorin in corneal angiogenesis. J Vasc Res 46, 541-550.
45. Mullaney BP & Skinner MK. (1992) Transforming growth factor-alpha and epidermal growth factor receptor gene expression and action during pubertal development of the seminiferous tubule. Mol Endocrinol 6, 2103-2113.
46. Nacov E. (1990) Tumor angiogenesis formation of vessels de novo at germ cell tumors. Cancer 66, 916-922.
47. Nawrocki-Raby B, Gilles C, Polette M, Bruyneel E, Laronze JY, Bonnet N, Foidart JM, Mareel M & Birembaut P. (2003) Up-regulation of MMPs by soluble E-cadherin in human lung tumor cells. Int J Cancer 105, 790-795.
48. Nowicki M, Konwerska A, Ostalska-Nowicka D, Derwich K, Miskowiak B, Kondraciuk B, Samulak D & Witt M. (2008) Vascular endothelial growth factor (VEGF)-C - a potent risk factor in children diagnosed with stadium 4 neuroblastoma. Folia Histochem Cytobiol 46, 493-499.
49. Oberbauer AM, Strong DD, Linkhart TA, Mohan S & Longo LD. (1993) Fibroblast growth factor enhances the transcription and stability of human chorionic gonadotropin beta-subunit messenger ribonucleic acid in Jar choriocarcinoma cells. Endocrinology 132, 757-762.
50. Olsson R, Maxhuni A & Carlsson PO. (2006) Revascularization of transplanted pancreatic islets following culture with stimulators of angiogenesis. Transplantation 82, 340-347.
51. Patan S. (2004) Vasculogenesis and angiogenesis. Cancer Treat Res 117, 3-32.
52. Petersen PM, Giwercman A, Hansen SW, Berthelsen JG, Daugaard G, Rørth M & Skakkebaek NE. (1999) Impaired testicular function in patients with carcinoma-in-situ of the testis. J Clin Oncol 17, 173-179.
53. Pezzolo A, Parodi F, Corrias MV, Cinti R, Gambini C & Pistoia V. (2007) Tumor origin of endothelial cells in human neuroblastoma. J Clin Oncol 25, 376-383.
54. Pokutta S & Weis WI. (2007) Structure and mechanism of cadherins and catenins in cell-cell contacts. Annu Rev Cell Dev Biol 23, 237-261.
55. Rajpert-De Meyts E. (2006) Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 12, 303-323.
56. Restucci B, Maiolino P, Papparella S & De Vico G. (2000) Expression of b1 integrin in relation to histological features in normal and neoplastic canine testicles. J Comp Pathol 123, 164-170.
57. Rigolin GM, Fraulini C, Ciccone M, Mauro E, Bugli AM, De Angeli C, Negrini M, Cuneo A & Castoldi G. (2006) Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion. Blood 107, 2531-2535.
58. Samson M, Peale FV, Jr, Frantz G, Rioux-Leclercq N, Rajpert-De Meyts E & Ferrara N. (2004) Human endocrine gland-derived vascular endothelial growth factor: expression early in development and in Leydig cell tumors suggests roles in normal and pathological testis angiogenesis. J Clin Endocrinol Metab 89, 4078-4088.
59. Shen R, Ye Y, Chen L, Yan Q, Barsky SH & Gao JX. (2008) Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS ONE 3, 1652.
60. Silván U, Arlucea J, Andrade R, Díez-Torre A, Silió M, Konerding MA & Aréchaga J. (2009a) Angiogenesis and vascular network of teratocarcinoma from embryonic stem cell transplant into seminiferous tubules. Br J Cancer 101, 64-70.
61. Silván U, Díez-Torre A, Arluzea J, Andrade R, Silió M & Aréchaga J. (2009b) Hypoxia and pluripotency in embryonic and embryonal carcinoma stem cell biology. Differentiation 78, 159-168.
62. Siu MK, Mruk DD, Lee WM & Cheng CY. (2003) Adhering junction dynamics in the testis are regulated by an interplay of beta 1-integrin and focal adhesion complex-associated proteins. Endocrinology 144, 2141-2163.
63. Slongo ML, Zampieri M & Onisto M. (2002) Expression of matrix metalloproteases (MMP-2, MT1 -MMP) and their tissue inhibitor (TIMP-2) by rat Sertoli cells in culture: implications for spermatogenesis. Biol Chem 383, 235-239.
64. Somanath PR, Ciocea A & Byzova TV. (2009a) Integrin and growth factor receptor alliance in angiogenesis. Cell Biochem Biophys 53, 53-64.
65. Somanath PR, Malinin NL & Byzova TV. (2009b) Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis. Angiogenesis 12, 177-185.
66. Stupack DG & Cheresh DA. (2003) Apoptotic cues from the extracellular matrix: regulators of angiogenesis. Oncogene 22, 9022-9029.
67. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR & Ellis LM. (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55, 3964-3968.
68. Tilki D, Kilic N, Herbst H, Reich O, Seitz M, Lauke H, Stief CG & Ergün S. (2008) High level of endostatin in epididymal epithelium: protection against primary malignancies in this organ? Histochem Cell Biol 130, 527-535.
69. Tummalapalli P, Spomar D, Gondi CS, Olivero WC, Gujrati M, Dinh DH & Rao JS. (2007) RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis. Int J Oncol 31, 1039-1050.
70. Tung PS & Fritz IB. (1990) Characterization of rat testicular peritubular myoid cells in culture: alpha-smooth muscle isoactin is a specific differentiation marker. Biol Reprod 42, 351-365.
71. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL & Wass JA. (2000) Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 85, 1159-1162.
72. Turpeenniemi-Hujanen T. (2005) Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochemie 87, 287-297.
73. Van Hinsbergh VW, Engelse MA & Quax PH. (2006) Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 26, 716-728.
74. Viglietto G, Romano A, Maglione D, Rambaldi M, Paoletti I, Lago CT et al. (1996) Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor. Oncogene 13, 577-587.
75. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Münstedt K, Rao CV, Lang U & Preissner KT. (2002) Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 87, 5290-5296.